While the U.S. cannabis industry grapples with regulatory stagnation, companies are diverging in their responses to the political gridlock. Green Thumb Industries CEO Ben Kovler recently voiced frustration over federal inertia, criticizing agencies like the DEA as "out of touch" and resistant to reform. Yet, amid this uncertainty, MMJ International Holdings has charted a … [Read more...] about MMJ’s FDA-First Cannabis Pharmaceutical Model Thrives Amid DEA Regulatory Gridlock
FDA
CBD Injections? Hard Pass – FDA Slams Injectable CBD, And Honestly, They Have a Point
Look, I love cannabis as much as the next rational human, but injecting CBD? That’s a hard no. The FDA just put the company Pico IV on blast for selling injectable CBD, and for once, I’m with them. This isn’t innovation—it’s stupidity in a syringe.CBD works just fine in oils, edibles, and topicals. Who looked at a perfectly good tincture and thought, “You know what this needs? … [Read more...] about CBD Injections? Hard Pass – FDA Slams Injectable CBD, And Honestly, They Have a Point
FDA greenlights study of marijuana as PTSD treatment for veterans
The Food and Drug Administration (FDA) has given the go-ahead for a controversial clinical trial to test whether marijuana can be used to treat combat veterans with post-traumatic stress disorder (PTSD). The long-delayed study is sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and had been delayed since 2021 due to several objections by … [Read more...] about FDA greenlights study of marijuana as PTSD treatment for veterans
FDA authorizes clinical trials to study cannabis use for veterans with PTSD
WASHINGTON — The Food and Drug Administration has authorized a non-for-profit company in California to proceed with clinical trials to study the effectiveness of smoking cannabis to treat post-traumatic stress disorder in veterans. MAPS — the Multidisciplinary Association for Psychedelic Studies — will initiate the short-term study of veterans who will smoke marijuana and … [Read more...] about FDA authorizes clinical trials to study cannabis use for veterans with PTSD
New FDA Report Highlights How Marijuana Rescheduling Review Analyzed Cannabis Users’ Social Media Posts
In another letter in December, 29 former U.S. attorneys called on the Biden administration to leave cannabis in Schedule I. Also that month, the governors of six U.S. states—Colorado, Illinois, New York, New Jersey, Maryland and Louisiana—sent a letter to Biden calling on the administration to reschedule marijuana by the end of last year. Meanwhile, six former DEA heads and … [Read more...] about New FDA Report Highlights How Marijuana Rescheduling Review Analyzed Cannabis Users’ Social Media Posts
How this proposed change could dramatically shift U.S. marijuana policy
The Biden administration is considering a major shift in the federal government’s policy on marijuana. In late August, the Department of Health and Human Services recommended that the Drug Enforcement Administration reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. The Food and Drug Administration has also concluded that marijuana should … [Read more...] about How this proposed change could dramatically shift U.S. marijuana policy
CBD Products Face New Regulatory Pathway as Market Booms
A display of CBD infused foot cream, vape pods, and massage oil products from Medical Mary are viewed at the 6th Annual Cannabis World Congress and Business Expo in Los Angeles in 2019. FDA to work with Congress to develop harm reduction approach. Agency also continuing look at how marijuana is classified. The Food and Drug Administration intends to collaborate with Congress … [Read more...] about CBD Products Face New Regulatory Pathway as Market Booms
U.S. FDA Calls for New Regulatory Framework for Use of Cannabis Compound CBD
The U.S. Food and Drug Administration said on Thursday it does not intend to make any new guidance on the use of the popular cannabis compound CBD in food and supplements, saying the United States needs to develop a new framework to ensure its safe use. The health regulator said it would work with Congress to develop a new, cross-agency regulatory framework. The FDA denied … [Read more...] about U.S. FDA Calls for New Regulatory Framework for Use of Cannabis Compound CBD
FDA finalizes guidance on cannabis clinical research
The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without running afoul of federal law. When Congress passed the Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill, it defined hemp as including cannabis … [Read more...] about FDA finalizes guidance on cannabis clinical research
Republican congressmen want answers from FDA on cannabis CBD regulations
A pair of By: Jonathan Block, on SeekingAlpha Republican congressmen are asking US FDA Commissioner Robert Califf to answer questions on why there is a lack of regulations on CBD, a compound found in cannabis also present in some food products and supplements. Reps. Morgan Griffith (R-Va) and Brett Guthrie (R-Ky) noted in a recent letter that while CBD, which is a … [Read more...] about Republican congressmen want answers from FDA on cannabis CBD regulations
